GreyBrook logotype
Investor Login Contact Us

Changing the Lives of More than 20,000 Patients, 2021 Was A Year of Continued Growth for Greenbrook TMS

Date:
December 31, 2021
Share:

Greenbrook TMS (NASDAQ: GBNH, TSX: GTMS) is a leading provider of TMS therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders founded by Greybrook and firm’s CEO, Bill Leonard, with 149 centres across the U.S. The company has provided nearly 1,000,000 treatments changing the lives of more than 20,000 patients and has achieved phenomenal growth over the past year through clinic acquisitions, and expansions into new therapies and treatment methods.

Greenbrook TMS was founded with the belief that mental health care as it then existed was failing too many people. Only 49% of patients respond to their first-round antidepressant medication. The other 51% endured lengthy cycles of medication trial-and-error with little improvement, often experiencing side effects like weight gain and sexual dysfunction which worsened their depression symptoms. We knew there had to be a better way.

In 2011, Greenbrook TMS opened its first location in Tysons Corner, Virginia, with a vision to bring together the best care teams and technology into a more personalized, more accessible, and most importantly more effective treatment experience.

Today, more than 10 years after launching that first centre, Greenbrook has provided nearly 1,000,000 treatments and changed the lives of more than 20,000 patients. “We have the largest clinical data set in the U.S., and our TMS patients experience a 62% response rate which is well above the current antidepressant medication therapy rates and that is for patients who have already failed other treatments”, explained Bill Leonard, CEO Greenbrook TMS. “Many of our patients achieve full remission from their depression symptoms—all with little to no side effects”.  With more than 40% growth since 2015, Greenbrook’s 149 centers span 17 states; each location offers state-of-the-art treatment technology in a soothing, spa-like environment, bringing the Greenbrook care experience to more communities. In early 2021, to complement Greenbrook’s deep expertise in depression treatment, the company piloted offering Spravato, a nasal esketamine spray that is FDA-approved for treatment resistant major depressive disorder.

“Our passion has always been fueled by the goal of changing patient’s lives for the better. Looking ahead, as the pandemic continues to disrupt all aspects of daily life, rates of depression continue to soar and the importance of and need for our work is greater than ever. To help meet treatment needs in the community, and building on our successes in 2021, we will expand our Spravato offering to 23 locations by the end of Q1 2022”.

“We are very proud of what the Greenbrook team has accomplished and their commitment to helping so many people. As we expand Greenbrook’s clinical footprint, we are excited to see the impact that TMS and other innovative therapies can have on the lives of patients struggling with mental health”, Elias Vamvakas, Chairman Greenbrook TMS and Chairman Greybrook Capital.

To learn more about Greenbrook TMS, visit www.greenbrooktms.com

 

Latest Insights

Toronto Ranks 4th in CBRE’s 2024 Top 50 North American Tech Talent Markets

Insights
November 29, 2024

The rise of artificial intelligence (AI) and the increasing adoption of technology across industries has led organizations to explore new ways to transform and streamline operations to stay competitive. As a result, the demand for tech talent has surged, often…

Boardroom Brief: EP. 04 – An Inside Look at How We Make Investment Decisions in Today’s Market

Insights
November 28, 2024

One of the most common questions we hear from investors is: How do we determine where to invest, especially as markets evolve? In today’s dynamic real estate landscape, making sound investment decisions requires a disciplined and selective approach. During a…

Inside Track 2024: Highlights from Our Annual Investor Event

Company News
November 14, 2024

We’re excited to share the highlights from Inside Track 2024, our annual investor event that offers industry-leading insights and engaging discussions on the future of real estate and the broader economy. This year, attendees had the opportunity to hear from…

Society Atlanta Now Accepting Applications for December Move-Ins

Portfolio Updates
November 13, 2024

Greybrook and our partners PMG, are pleased to announce that pre-leasing has commenced for Society Atlanta. Located at 811 Peachtree St. NE, Society Atlanta is a 31-story tower featuring 460 rental apartments, over 87,000 square feet of office space and…

Archetto Towns Takes Shape Amid Vibrant Backdrop of Fall Foliage

Portfolio Updates
November 8, 2024

We recently had the opportunity to fly over our Archetto Towns project in Woodbridge, offering a new perspective of our 91 townhomes low-rise community. Standing out against the eye-catching backdrop of vibrant fall foliage, this exclusive collection of contemporary townhomes,…

Artistry Condos Celebrates Key Construction Milestone with Topping Off Ceremony

Portfolio Updates
November 6, 2024

We are thrilled to announce that our Artistry Condos high-rise development in Toronto’s vibrant Grange Park community has reached a significant milestone with the successful topping-off of the building. This achievement marks the completion of the structural formwork at its…

Linx Condos Receives Heritage Toronto Award Nomination

Portfolio Updates
November 5, 2024

We are proud to share that Linx Condos was recently nominated for the prestigious Heritage Toronto Awards in the Built Heritage category. This year’s 49th Annual Heritage Toronto Awards celebrated exceptional contributions to the preservation and evolution of the city’s…

Sasha Cucuz Joins the Latest Episode of Toronto Under Construction to Take a Deep Dive into Real Estate Investment

Insights
October 28, 2024

In the latest episode of the Toronto Under Construction podcast, CEO Sasha Cucuz joins Bullpen Consulting’s Ben Myers and guest co-host Matt Young for an in-depth discussion on real estate investment. The conversation offers insights into Greybrook’s evolution, highlighting its strategic…

Boardroom Brief: EP. 03 – Ontario’s New Provincial Planning Statement, 2024: What Impact Will it Have?

Insights
October 23, 2024

On October 20th, 2024, the Ontario government’s Provincial Planning Statement, 2024 (PPS 2024) came into effect, aiming to streamline the province’s land use planning framework. This new policy replaces both the Provincial Policy Statement, 2020, and A Places to Grow:…

Inside Track 2024: Economic Insights from CIBC’s Benjamin Tal and CEO Perspectives on the Current & Future Real Estate Market

Company News
October 22, 2024

The evening featured the prominent Benjamin Tal, Deputy Chief Economist and Managing Director of CIBC World Markets, who delivered his expert analysis of macroeconomic data and real estate trends in the Canadian market. Following his keynote, attendees enjoyed an engaging…

[geot_filter exclude_country="cn"]All Publications[/geot_filter][geot_filter country="cn"]所有出版物[/geot_filter]

Join our newsletter and keep up to date with our news & insights

Contact us